wang, L. (2025) “Clinical Progress of Targeted KRAS Drugs Combined with Immune Checkpoint Inhibitors in the Treatment of Pancreatic Cancer”, Transactions on Materials, Biotechnology and Life Sciences, 8, pp. 397–402. doi:10.62051/rq7x6r98.